Download the appMore options
PisaczekSearch
文AEN-US
Vitamins and mineralsStudies updated this month

Vitamin C and cancer — why does this topic still divide doctors?

Sources: 14 · Article: 16 576 characters ↓

What do Natural Therapy Specialists write?

Jerzy Zięba

In the study described, a fasting-mimicking diet and vitamin C reduced the growth of cancer cells in mice, and combining the two had a strong effect.

„The studies were conducted on mice, not humans, and the scientists studying the effects of vitamin C themselves see potential in it. “Used alone, a fasting-mimicking diet or vitamin C alone reduced the growth of cancer cells and caused a slight increase in cancer cell death,” says Prof.”Badania przeprowadzono na myszach, nie na ludziach, a sami naukowcy, którzy badają działanie witaminy C widzą potencjał. „„Stosowana samodzielnie dieta naśladująca post lub sama witamina C zmniejszały wzrost komórek rakowych i powodowały niewielki wzrost śmierci komórek rakowych”, mówi Prof.
Jerzy Zięba

Nine people with advanced pancreatic cancer were given intravenous vitamin C along with chemotherapy, and the disease did not progress for six months after treatment.

„The disease did not progress in their bodies during the six months after treatment ended. We need more experiments and studies like these, as well as more publications. For years, I have argued that vitamin C is effective against cancer, but only when it is used in the right way and in the right amounts.”Choroba nie poczyniła postępów w ich organizmach w ciągu pół roku od zakończenia kuracji. Aby więcej takich eksperymentów i badań, a także publikacji. Od lat przekonuję, że witamina C jest skuteczna przy nowotworach, ale wyłącznie, gdy jest stosowana w odpowiedni sposób i właściwych ilościach.
Jerzy Zięba

Jerzy Zięba believes that oral administration involves too low a dose for the results to be convincing, and stresses the importance of the form and method of administration.

„The reason is that the amounts are too low and that the vitamin C is given orally. Nevertheless, this is a Polish study, one of the few. I hope these unspectacular results will not discourage other scientists from studying the use of vitamin C in cancer.”Powodem tego są zbyt niskie ilości oraz fakt, że witamina C będzie podawana doustnie. Niemniej jest to polskie badanie, jedno z niewielu. Mam nadzieję, że te niespektakularne wyniki nie zniechęca kolejnych naukowców do prowadzenia badań nad wykorzystaniem witaminy C w nowotworach.
Andrzej Frydrychowski

Andrzej Frydrychowski claims that giving high doses of vitamin C intravenously is prohibited and may lead to disciplinary proceedings before medical chambers.

„Giving such doses intravenously is prohibited. Anyone who administers vitamin C this way will face a case before the medical chambers. Explaining that this method is recommended in hundreds of scientific publications gets nowhere. Our esteemed colleagues sitting on medical chambers and courts are deaf to all scientific arguments.”Podawanie dożylne w takich dawkach jest zabronione. Kto w ten sposób poda witaminę C ma sprawę w Izbach Lekarskich. Tłumaczenie, że metoda ta jest polecana w setkach publikacji naukowych, nic nie daje. Szanowni koledzy zasiadający w Izbach i Sądach Lekarskich są głusi na wszelkie naukowe argumenty.
Andrzej Frydrychowski

Andrzej Frydrychowski believes that scientific arguments do not persuade those who handle such cases, and links the restrictions to a ban on inexpensive treatment.

„Explaining that this method is recommended in hundreds of scientific publications gets nowhere. Our esteemed colleagues sitting on medical chambers and courts are deaf to all scientific arguments. This is one of many absurdities in our country. I am the best proof of this myself: the medical chambers accused me of lacking the qualifications to treat patients because I use and recommend what I wrote above.”Tłumaczenie, że metoda ta jest polecana w setkach publikacji naukowych, nic nie daje. Szanowni koledzy zasiadający w Izbach i Sądach Lekarskich są głusi na wszelkie naukowe argumenty. Jest to jeden z wielu absurdów naszego kraju. Sam jestem tego najlepszym dowodem: Izby Lekarskie zarzuciły mi brak kompetencji leczenia, ponieważ stosuję i polecam to, co napisałem powyżej.
Hubert Czerniak

Hubert Czerniak presents deficiencies in vitamins C and D as a cause of weakened collagen structures.

„Reduced cohesion of collagen structures in blood vessels resulting from a trivial cause such as vitamin deficiencies. Vitamins C and D are especially relevant here. It is worth recalling why this happens: because our food is crap. In the Gierek era, Polish farmers growing crops used manure containing a whole range of essential micro- and macronutrients.”Obniżenie spójności struktur kolagenowych w naczyniach krwionośnych wynikające z błahej przyczyny jak niedobór witamin. Szczególnie chodzi o witaminy C i D. Warto przypomnieć, dlaczego tak się dzieje? Ponieważ nasze pożywienie jest gówni…e. W czasach gierkowskich polski rolnik uprawiając rośliny, korzystał z obornika zawierającego cały wachlarz niezbędnych mikro- i makroelementów.

What does scientific research from PubMed · Europe PMC say?

We selected 8 studies with the best, positive results. This is a selection, not a full review of all research.

Total number of studies on this topic in PubMed: 7 393.

Aim of the study: Intravenous vitamin C (IVC) is a controversial complementary cancer therapy, widely used in naturopathic and integrative oncology settings. We conducted a systematic review of human interventional and observational studies assessing IVC use in cancer patients.

Results: Of 897 records, a total of 39 reports from 37 studies were included: 2 randomized controlled trials (RCTs), 15 uncontrolled trials, 6 observational studies, and 14 case reports. IVC doses ranged from 1 g to more than 200 g of ascorbic acid per infusion, typically given 2 to 3 times a week. IVC does not appear to increase toxicity or interfere with the antitumor effects of gemcitabine/erlotinib therapy or paclitaxel and carboplatin. Based on 1 RCT and data from uncontrolled human trials, IVC may improve time to relapse and possibly help reduce tumor mass and improve survival when combined with chemotherapy. IVC may improve quality of life, physical function, and chemotherapy-related side effects, including fatigue, nausea, insomnia, constipation, and depression. Case reports document several instances of tumor regression and long-term survival without disease associated with IVC use. There is limited high-quality clinical evidence on the safety and effectiveness of IVC.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyreview of many studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The association between dietary vitamin C intake and breast cancer survival is inconsistent, and few studies have specifically examined vitamin C supplement use among women with breast cancer. The purpose of this study was to summarize results from prospective studies on the association between vitamin C supplement use and dietary vitamin C intake and breast cancer-specific and overall mortality.

Results: The ten identified studies examined vitamin C supplement use (n=6) and dietary vitamin C intake (n=7) and included 17,696 breast cancer cases, 2791 total deaths, and 1558 breast cancer-specific deaths. The summary RR (95% CI) for vitamin C supplement use after diagnosis was 0.81 (95% CI 0.72-0.91) for overall mortality and 0.85 (95% CI 0.74-0.99) for breast cancer-specific mortality. The summary RR for a 100mg per day increase in dietary vitamin C intake was 0.73 (95% CI 0.59-0.89) for overall mortality and 0.78 (95% CI 0.64-0.94) for breast cancer-specific mortality. The results of this meta-analysis suggest that vitamin C supplement use after diagnosis may be associated with a reduced risk of mortality. Dietary vitamin C intake was also statistically significantly associated with a reduced risk of overall and breast cancer-specific mortality.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studycombined analysis of many studies (meta-analysis)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Skin cancer is the most common cancer in the United States and among Caucasians worldwide, with more people diagnosed each year than with all other cancers combined. Basal cell cancer is the most common form, with an estimated 4.3 million cases diagnosed annually and treatment costs estimated at $4.8 billion.

Results: After 8 weeks, post-treatment biopsies showed complete resolution of 13/15 (86.7%) lesions in the ascorbic acid group, while 8/14 (57.1%) lesions in the IMQ group had resolved (p < 0.05 Chi Square). Topical ascorbic acid was superior at 8 weeks and non-inferior at 12 weeks to topical imiquimod for treating low-risk nodular and superficial lesions. In addition, ascorbic acid was associated with fewer adverse effects than imiquimod. At the 30mo follow-up, 70% of patients in the imiquimod group showed residual hypopigmentation, compared with 0% in the ascorbate group.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studystudy with random allocation to groups (RCT)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: More than half of human colorectal cancers (CRCs) have either KRAS or BRAF mutations and are often resistant to approved targeted therapies. We found that cultured human CRC cells with KRAS or BRAF mutations are selectively killed when exposed to high levels of vitamin C.

Results: As a result, reactive oxygen species accumulate and inactivate glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Inhibition of GAPDH in highly glycolytic KRAS- or BRAF-mutant cells leads to an energy crisis and cell death, which is not seen in KRAS- and BRAF-wild-type cells. High-dose vitamin C impairs tumor growth in Apc/Kras(G12D) mutant mice. These results provide a mechanistic rationale for exploring the therapeutic use of vitamin C for CRCs with KRAS or BRAF mutations.

Money for the studygovernment, public institutions · National Cancer Institute, NIA NIH HHS, Damon Runyon Cancer Research Foundation
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Vitamin C is an antioxidant with a potential role in preventing digestive system cancers, but there is still no consensus on whether vitamin C plays a causal role in these cancers. The aim of this study was to use Mendelian randomization to investigate potential causal associations between vitamin C and the risk of digestive system cancers.

Results: Genetically predicted higher circulating vitamin C showed a suggestive association with lower risk of small intestine and colorectal cancer after accounting for multiple testing. The odds ratio per 1 standard deviation increase in circulating vitamin C was 0.55 (95% confidence interval 0.32-0.94; P = 0.029) for small intestine cancer and 0.84 (95% confidence interval 0.73-0.96; P = 0.013) for colorectal cancer. There was a suggestive association between genetically predicted higher circulating vitamin C and lower risk of liver cancer in FinnGen, but no association in the meta-analysis (odds ratio 0.69; 95% CI 0.36-1.32; P = 0.265). Genetically predicted circulating vitamin C was not associated with cancers of the esophagus, stomach, or pancreas. This Mendelian randomization study indicates that vitamin C might play a role in preventing small intestine and colorectal cancer.

Money for the studygovernment, public institutions · Wellcome Trust, Medical Research Council, National Institute for Health Research (NIHR)
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studycombined analysis of many studies (meta-analysis)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Growing evidence indicates that vitamin C may be a powerful anticancer agent when given intravenously and in high doses (high-dose IVC). Early-phase clinical trials have confirmed the safety of IVC and indicated that it may be effective in eliminating tumor cells in various types of cancer.

Results: Therefore, there is a need for greater awareness of the use of this highly promising, non-toxic cancer treatment in clinical settings. In this review, we provide a detailed overview of preclinical and clinical studies using high-dose IVC as an anticancer agent, as well as a detailed assessment of the main known molecular mechanisms involved. We place special focus on global molecular profiling studies in this area. In addition, we discuss the future implications of high-dose vitamin C in cancer treatment and make recommendations for further research.

Money for the studyuniversity or foundation · kwf kankerbestrijding
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Evidence on antioxidant vitamin intake and esophageal cancer risk in Asian populations remains limited. Given sex differences in incidence and major risk factors, we examined sex-specific associations in a large Japanese cohort.

Results: During a median 15.6-year follow-up, 497 participants (447 men and 50 women) developed esophageal cancer, including 424 cases of squamous cell carcinoma. Among men, higher vitamin C intake was associated with lower risk (HR for the highest-versus-lowest quartile, 0.62; 95% CI, 0.46-0.85; P for trend = 0.036). Among women, the corresponding HR was 0.71 (95% CI, 0.31-1.63; P for trend = 0.465). Among male never-smokers, an inverse association was observed (HR, 0.35; 95% CI, 0.14-0.70; P for trend = 0.032), whereas no clear association was found among male ever-smokers. Other antioxidant vitamins showed no clear associations. Higher dietary vitamin C intake was associated with lower esophageal cancer risk among men, particularly never-smokers. The limited number of cases did not allow a clear interpretation for women.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyobservation of people
Participants83 404

“Not stated” does not mean nobody paid — the database does not always record it.

„KHSRP depletion therefore enhanced the synergistic cytotoxicity of vitamin C and uric acid, particularly in therapy-persistent leukemia cells. Re-expression of TET2 overrode the chemosensitizing effect of KHSRP depletion in TET2-mutant leukemia, suggesting that KHSRP-linked phenotypes were related to vitamin C- and uric acid-mediated TET activation.”KHSRP depletion therefore enhanced the synergistic cytotoxicity of vitamin C and uric acid, particularly in therapy-persistent leukemia cells. Re-expression of TET2 overrode the chemosensitizing effect of KHSRP depletion in TET2-mutant leukemia, suggesting that KHSRP-linked phenotypes were related to vitamin C- and uric acid-mediated TET activation.
Money for the studyuniversity or foundation · Break Through Cancer (BTC), Leukemia and Lymphoma Society, Leukemia and Lymphoma Society (LLS)
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

What do orthomolecular medicine doctors write?

Orthomolecular Medicine News Service
„Both the American Cancer Society and Cancer Research UK have downplayed or completely ignored decades of physician reports and controlled clinical studies indicating that vitamin C stops cancer. Worse, each of these supposedly comprehensive cancer research and education organizations continues to actively discourage people from using vitamin C against cancer. Look for yourself and see.”Both the American Cancer Society and Cancer Research UK have downplayed or flatly ignored decades of physician reports and controlled clinical studies indicating that vitamin C stops cancer. What's worse, each of these supposedly comprehensive cancer research and education organizations continues to actively discourage people from using vitamin C against cancer. Look for yourself and see.
Orthomolecular Medicine News Service
„His publication list follows.) Publications: Effects of High Dose Vitamin C for Cancer Patients -- Nine Cases [1] Vitamin C - The Remarkable Story of Controversy [2] The Missing Link In Cancer Treatment: High Dose Vitamin C [3] High Dose Intravenous Vitamin C and Radiotherapy Reversing Vocal Cord Palsy Caused by Lung Cancer: A Case Report [9] High Dose Vitamin C helps prevent recurrence of Stage IV Ovarian Cancer. A case report [17] Embracing cancer immunotherapy with vital micronutrients [19] Off-Label Cancer Prescription: A Paradox to Evidence-Based Medicine [26] References: [1] Yuen RCF, Glenda CSL, Meng LK.”His publication list follows.) Publications: Effects of High Dose Vitamin C for Cancer Patients -- Nine Cases [1] Vitamin C - The Remarkable Story of Controversy [2] The Missing Link In Cancer Treatment: High Dose Vitamin C [3] High Dose Intravenous Vitamin C and Radiotherapy Reversing Vocal Cord Palsy Caused by Lung Cancer: A Case Report [9] High Dose Vitamin C helps prevent recurrence of Stage IV Ovarian Cancer. A case report [17] Embracing cancer immunotherapy with vital micronutrients [19] Off-Label Cancer Prescription: A Paradox to Evidence-Based Medicine [26] References: [1] Yuen RCF, Glenda CSL, Meng LK.
Orthomolecular Medicine News Service
„The NIH says, "Studies of dietary intake suggest an association between diets rich in beta-carotene and vitamin A and a lower risk of many types of cancer. A higher intake of green and yellow vegetables or other food sources of beta-carotene and/or vitamin A may decrease the risk of lung cancer." (9) A study of over 82,000 people showed that high vitamin A intake cuts the risk of stomach cancer by half. (10) Dr. Jennifer Brett comments that "Vitamin A fights cancer by inhibiting the production of DNA in cancerous cells."”The NIH says, "Dietary intake studies suggest an association between diets rich in beta-carotene and vitamin A and a lower risk of many types of cancer. A higher intake of green and yellow vegetables or other food sources of beta carotene and/or vitamin A may decrease the risk of lung cancer." (9) A study of over 82,000 people showed that high intakes of vitamin A reduce the risk of stomach cancer by one-half. (10) Dr. Jennifer Brett comments that "Vitamin A fights cancer by inhibiting the production of DNA in cancerous cells.

Sources (14)

Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.